Tetrahexosylceramide (d18:1/20:0)

11034-93-8

Eicosanamide, N-[(1S,2R,3E)-1-[[[O-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl-(1->3)-O-α-D-galactopyranosyl-(1->4)-O-β-D-galactopyranosyl-(1->4)-β-D-mannopyranosyl]oxy]methyl]-2-hydroxy -3-heptadecen-1-yl]-

N-[(2S,3R,4E)-1-{[2-Acetamido-2-deoxy-β-D-galactopyranosyl-(1->3)-α-D-galactopyranosyl-(1->4)-β-D-galactopyranosyl-(1->4)-β-D-mannopyranosyl]oxy}-3-hydroxy-4-octadecen-2-yl]icosanamide

N-[(2S,3R,4E)-1-{[2-Acetamido-2-desoxy-β-D-galactopyranosyl-(1->3)-α-D-galactopyranosyl-(1->4)-β-D-galactopyranosyl-(1->4)-β-D-mannopyranosyl]oxy}-3-hydroxy-4-octadecen-2-yl]icosanamid

N-[(2S,3R,4E)-1-{[2-Acétamido-2-désoxy-β-D-galactopyranosyl-(1->3)-α-D-galactopyranosyl-(1->4)-β-D-galactopyranosyl-(1->4)-β-D-mannopyranosyl]oxy}-3-hydroxy-4-octadécén-2-yl]icosanamide

Tetrahexosylceramide (d18:1/20:0)

CQH

Cytolipin K

GalNAc-β1->3Gal-α1->3Gal-β1->4Glc-β1->1′Cer

Ganglioside Gb4

Ganglioside GL 4

Gb4Cer

Globo-N-tetraosylceramide

Globosidate

Globoside

Globoside Gb 4

Globoside GL 4

Globoside I

Globosidic acid

Globotetraosylceramide

iGb4Cer

N-[(2S,3R,4E)-1-{[(2R,4R,5S,6R)-5-{[(2S,3R,4R,5R,6R)-5-{[(2R,3R,4S,5S,6R)-4-{[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3

N-[(2S,3R,4E)-1-{[(2R,4R,5S,6R)-5-{[(2S,3R,4R,5R,6R)-5-{[(2R,3R,4S,5S,6R)-4-{[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydr

N-Acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide

N-Acetyl-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide

N-Acetyl-galactosaminyl-1,3-δ-galactosyl-1,4-δ-galactosyl-1,4-δ-glucosylceramide

N-Acetyl-δ-galactosaminyl-1,3-δ-galactosyl-1,4-δ-galactosyl-1,4-δ-glucosylceramide

Parvovirus B19 receptor